New York[email protected] | (212) 271-3741 | v-Card
Nathan is a Director in the Equity Capital Markets Group focusing on equity transactions for both public and private healthcare companies. He has completed over 200 financings for healthcare issuers since 2012 including IPOs, marketed and confidentially marketed follow-ons, registered directs, PIPEs, and private placements. Nathan has over 10 years of experience in Equity Capital Markets and Investment Banking.
Nathan joined Stifel as an Associate in the Technology Investment Banking Group in 2010 and subsequently joined the Healthcare Capital Markets Group in 2012. Prior to Stifel, he was an Analyst in the Technology Investment Banking Group at ThinkEquity Partners.
Nathan holds a B.A. from Miami University.